Progress in Skin Cancer Research PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Progress in Skin Cancer Research PDF full book. Access full book title Progress in Skin Cancer Research by V. L. Heinz. Download full books in PDF and EPUB format.
Author: V. L. Heinz
Publisher: Nova Publishers
ISBN: 9781600210952
Category : Skin
Languages : en
Pages : 208
Get Book
Book Description
Three types of skin cancer account for nearly 100 per cent of all diagnosed cases. Each of these three cancers begins in a different type of cell within the skin, and each cancer is named for the type of cell in which it begins. Skin cancers are divided into one of two classes - non-melanoma skin cancers and melanoma. Melanoma is the deadliest form of skin cancer. The different types of skin cancer are: Basal cell carcinoma (BCC); Squamous cell carcinoma (SCC); and Melanoma. All other skin cancers combined account for less than 1 per cent of diagnosed cases. These are classified as non-melanoma skin cancers and include Merkel cell carcinoma, dermatofibromasarcoma protuberans, Paget's disease and cutaneous T-cell lymphoma. This book examines the latest research in this field.
Author: V. L. Heinz
Publisher: Nova Publishers
ISBN: 9781600210952
Category : Skin
Languages : en
Pages : 208
Get Book
Book Description
Three types of skin cancer account for nearly 100 per cent of all diagnosed cases. Each of these three cancers begins in a different type of cell within the skin, and each cancer is named for the type of cell in which it begins. Skin cancers are divided into one of two classes - non-melanoma skin cancers and melanoma. Melanoma is the deadliest form of skin cancer. The different types of skin cancer are: Basal cell carcinoma (BCC); Squamous cell carcinoma (SCC); and Melanoma. All other skin cancers combined account for less than 1 per cent of diagnosed cases. These are classified as non-melanoma skin cancers and include Merkel cell carcinoma, dermatofibromasarcoma protuberans, Paget's disease and cutaneous T-cell lymphoma. This book examines the latest research in this field.
Author: U.s. Department of Health and Human Services
Publisher: Createspace Independent Publishing Platform
ISBN: 9781502903853
Category : Medical
Languages : en
Pages : 112
Get Book
Book Description
Skin cancer is the most commonly diagnosed cancer in the United States, yet most cases are preventable. Every year in the United States, nearly 5 million people are treated for skin cancer, at an estimated cost of $8.1 billion. Melanoma, the most deadly form of skin cancer, causes nearly 9,000 deaths each year. Despite recent efforts to address risk factors, skin cancer rates continue to rise. While those with lighter skin are more susceptible, anyone can get skin cancer—and it can be serious, even deadly. Almost all of the conditions can be caused by unnecessary ultraviolet (UV) radiation exposure, usually from excessive time in the sun or from the use of indoor tanning devices. It is alarming that every year, nearly one out of every three young white women aged 16–25 engages in indoor tanning. It's important to shatter the myth that tanned skin is a sign of health. And a “base” tan is not a “safe” tan. Tanned skin is damaged skin. Understanding the risk of UV exposure is crucial to protecting ourselves and our loved ones. That is why “The Surgeon General's Call to Action to Prevent Skin Cancer” is important for all of us. It outlines action steps we can all take—as individuals, parents, educators, employers, policy makers, health care professionals, and communities—to reverse this alarming trend. As a nation, we can all do more to address skin cancer as a serious public health challenge. Everyone is urged to find out more about the risk of skin cancer—and what we all can do to prevent it.
Author:
Publisher:
ISBN:
Category : Skin
Languages : en
Pages : 16
Get Book
Book Description
Author:
Publisher:
ISBN:
Category :
Languages : en
Pages :
Get Book
Book Description
Author: April Armstrong
Publisher: BoD – Books on Demand
ISBN: 9533075759
Category : Medical
Languages : en
Pages : 268
Get Book
Book Description
This book titled Advances in Malignant Melanoma - Clinical and Research Perspectives represents an international effort to highlight advances in our understanding of malignant melanoma from both clinical and research perspectives. The authors for this book consist of an international group of recognized leaders in melanoma research and patient care, and they share their unique perspectives regarding melanoma epidemiology, risk factors, diagnostic and prognostic tools, phenotypes, treatment, and future research directions. The book is divide into four sections: (1) Epidemiology and Risk Factors of Melanoma, (2) Clinical Phenotypes of Melanoma, (3) Investigational Treatments for Melanoma and Pigmentary Disorders, and (4) Advances in Melanoma Translational Research. This book does not attempt to exhaustively cover all aspects of the aforementioned topics. Rather, it is a compilation of our authors' pearls and unique perspectives on the relevant advances in melanoma during the recent years.
Author: MD Maritza Perez
Publisher: Lulu.com
ISBN: 9781329307988
Category : Health & Fitness
Languages : en
Pages : 104
Get Book
Book Description
This valuable handbook, written by two renowned dermatologists, is for melanoma patients, their families, friends, health professionals, and every person interested in staying healthy. Complete with full-color photographs, a specially compiled list of support groups and services, and a glossary.
Author: Miroslav Blumenberg
Publisher: BoD – Books on Demand
ISBN: 1789230942
Category : Medical
Languages : en
Pages : 214
Get Book
Book Description
Human skin cancers, the most common type of tumors, represent a significant health burden. The deadliest is unquestionably melanoma. Half of melanomas have an activating mutation in the BRAF gene, prompting development of novel drugs, vemurafenib and dabrafenib, specifically targeting mutated BRAF. Trametinib and cobimetinib, which block MEK, a BRAF effector protein, have been used in combination with BRAF inhibitors. A promising new melanoma treatment is immunotherapy, approach that boosts patient's own immune system to attack cancer. Pembrolizumab and nivolumab inhibit PD-1, whereas Ipilimumab targets CTLA-4, another immunity check point, to boost the immune response. Here we focus on pathways, mechanisms, targets and treatments of human skin cancers, with particular emphasis on the new developments in the research on melanomas.
Author: Giuseppe Argenziano
Publisher: Academic Press
ISBN: 0128040319
Category : Medical
Languages : en
Pages : 252
Get Book
Book Description
Cutaneous Melanoma: A Pocket Guide for Diagnosis and Management serves as an easy-to-consult, short, and schematic reference providing guidelines for diagnosing and managing melanoma in the context of various clinical scenarios. In the daily routine of a busy clinician, there is a need for schematic reference tools that allow quick consultation for immediate decisions. Melanoma is a deadly disease that should be promptly managed following precise and evidence-based guidelines. The guide contains many schematics and figures, vastly outnumbering the pages dedicated to text. This guide follows the sequence of a real clinical setting, going from the first screening visit to the final stages of terminal patients. Provides a quick-access resource for diagnosis and treatment of melanoma patients at all stages Includes succinct guidelines, schematics, and figures for busy clinicians Concludes with a section addressing special clinical situations, including melanoma in pregnancy, pediatric melanoma, familial melanoma and MPM, atypical Spitz tumor, occult primary melanoma, and the histopathologic gray zone
Author: Taku Fujimura
Publisher: Frontiers Media SA
ISBN: 2889663272
Category : Medical
Languages : en
Pages : 129
Get Book
Book Description
Author: Howard L. Kaufman
Publisher: Springer
ISBN: 3319225391
Category : Medical
Languages : en
Pages : 416
Get Book
Book Description
Melanoma is one of the most types of cancer. When melanoma is detected at an early stage, treatment is highly successful, but outcomes can be poor when the disease is advanced. There has been significant progress in our understanding of the molecular biology, genetics, and immunology of melanoma over the past decade. This has been accompanied by rapid advances in therapeutic strategies for patients with melanoma. This book provides the clinician and the researcher with a broad understanding of the molecular and cellular pathogenesis of melanoma, explores the clinical characteristics and criteria for clinical and pathological staging of the disease, and provides an overview of current and evolving treatment strategies in the adjuvant, metastatic, and preventive settings. The treatment of special populations and rare variants of melanoma that often present particular clinical challenges is also covered. Authored by international experts in melanoma biology and clinical management, this volume concisely explains how to diagnose, treat, and prevent melanoma while reviewing advances in basic science and providing an overview of innovative approaches still under development.
